Tumor-associated gastroparesis with esophageal carcinoma. Use of intravenous metoclopramide during radionuclide gastric emptying studies to predict clinical response.
This case report describes a patient with esophageal carcinoma and tumor-associated gastroparesis. The radionuclide gastric emptying study diagnosed very delayed liquid and solid gastric emptying. Metoclopramide was administered intravenously during the study and was able to predict a good response to oral therapy.
Choe
A I
AI
Department of Radiology, Georgetown University Medical Center, Washington, D.C.
Ziessman
H A
HA
Fleischer
D E
DE
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000150:complications*; D004938:Esophageal Neoplasms / Q000150:complications*; D005746:Gastric Emptying / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008787:Metoclopramide / Q000627:therapeutic use*; D009942:Organometallic Compounds; D004369:Pentetic Acid; D011877:Radionuclide Imaging; D013272:Stomach Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D013667:Technetium; D016284:Technetium Tc 99m Pentetate
D009942:Organometallic Compounds; D013667:Technetium; D004369:Pentetic Acid; D008787:Metoclopramide; D016284:Technetium Tc 99m Pentetate